Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combivent vs Salbutamol in Asthmatic Children with Severe Acute Exacerbation
NCT00273962Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2002
- Primary completion
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ipratropium bromide in asthma (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Proportion of patients showing improvement in asthma severity scores from severe at baseline to mild at the end of the treatment. Started May 2002; status: completed.
02
Drugs
ipratropium bromide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00273962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273962.